Navamedic ASA (OSL: NAVA)
Norway
· Delayed Price · Currency is NOK 25.90
-0.80 (-3.00%)
Nov 22, 2024, 2:58 PM CET
Navamedic ASA Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 525.55 | 512 | 382.14 | 278.44 | 209.88 | 188.76 | Upgrade
|
| Revenue Growth (YoY) | 4.56% | 33.98% | 37.24% | 32.67% | 11.19% | 2.63% | Upgrade
|
| Cost of Revenue | 315.24 | 312.94 | 218.62 | 166.7 | 139.54 | 131.15 | Upgrade
|
| Gross Profit | 210.31 | 199.05 | 163.52 | 111.74 | 70.34 | 57.6 | Upgrade
|
| Selling, General & Admin | 68.83 | 63.67 | 48.09 | 44.46 | 32.57 | 33.36 | Upgrade
|
| Other Operating Expenses | 83.82 | 83.82 | 63.75 | 49.12 | 39.03 | 30.7 | Upgrade
|
| Operating Expenses | 168.21 | 159.41 | 119.08 | 100.29 | 75.26 | 67.69 | Upgrade
|
| Operating Income | 42.1 | 39.64 | 44.45 | 11.46 | -4.93 | -10.09 | Upgrade
|
| Interest Expense | -7.36 | -7.77 | -0.61 | -2.5 | -2.71 | -1.78 | Upgrade
|
| Interest & Investment Income | 4.21 | 4.21 | 3.08 | 2.79 | 2.52 | 0.01 | Upgrade
|
| Earnings From Equity Investments | - | - | -1.1 | -3.19 | -4.53 | -0.7 | Upgrade
|
| Currency Exchange Gain (Loss) | 5.94 | 5.94 | -9.24 | -5.52 | -6.14 | -2.58 | Upgrade
|
| Other Non Operating Income (Expenses) | -6.43 | -6.43 | 13.58 | -0.68 | -0.81 | -0.35 | Upgrade
|
| EBT Excluding Unusual Items | 38.46 | 35.59 | 50.15 | 2.36 | -16.6 | -15.48 | Upgrade
|
| Merger & Restructuring Charges | -2.61 | -16.06 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -8.7 | -8.7 | -7.64 | - | - | - | Upgrade
|
| Pretax Income | 27.15 | 10.83 | 42.51 | 2.36 | -16.6 | -15.48 | Upgrade
|
| Income Tax Expense | 7.53 | 7.53 | 13.07 | 1.74 | -0.14 | 0.82 | Upgrade
|
| Earnings From Continuing Operations | 19.62 | 3.3 | 29.43 | 0.62 | -16.46 | -16.3 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | - | - | 44.23 | Upgrade
|
| Net Income | 19.62 | 3.3 | 29.43 | 0.62 | -16.46 | 27.94 | Upgrade
|
| Net Income to Common | 19.62 | 3.3 | 29.43 | 0.62 | -16.46 | 27.94 | Upgrade
|
| Net Income Growth | -36.51% | -88.77% | 4662.46% | - | - | 283.52% | Upgrade
|
| Shares Outstanding (Basic) | - | 17 | 17 | 16 | 14 | 12 | Upgrade
|
| Shares Outstanding (Diluted) | - | 18 | 17 | 16 | 14 | 12 | Upgrade
|
| Shares Change (YoY) | - | 3.47% | 3.60% | 13.61% | 23.54% | 7.71% | Upgrade
|
| EPS (Basic) | - | 0.19 | 1.75 | 0.04 | -1.14 | 2.39 | Upgrade
|
| EPS (Diluted) | - | 0.19 | 1.73 | 0.04 | -1.14 | 2.39 | Upgrade
|
| EPS Growth | - | -89.13% | 4459.36% | - | - | 256.06% | Upgrade
|
| Free Cash Flow | 7.08 | -0.02 | 15.69 | -2.02 | -3.35 | 11.99 | Upgrade
|
| Free Cash Flow Per Share | - | -0.00 | 0.92 | -0.12 | -0.23 | 1.02 | Upgrade
|
| Gross Margin | 40.02% | 38.88% | 42.79% | 40.13% | 33.51% | 30.52% | Upgrade
|
| Operating Margin | 8.01% | 7.74% | 11.63% | 4.11% | -2.35% | -5.34% | Upgrade
|
| Profit Margin | 3.73% | 0.65% | 7.70% | 0.22% | -7.84% | 14.80% | Upgrade
|
| Free Cash Flow Margin | 1.35% | -0.00% | 4.11% | -0.72% | -1.60% | 6.35% | Upgrade
|
| EBITDA | 55.26 | 49.16 | 49.62 | 16.15 | -2.76 | -7.89 | Upgrade
|
| EBITDA Margin | 10.51% | 9.60% | 12.99% | 5.80% | -1.32% | -4.18% | Upgrade
|
| D&A For EBITDA | 13.16 | 9.52 | 5.18 | 4.69 | 2.16 | 2.19 | Upgrade
|
| EBIT | 42.1 | 39.64 | 44.45 | 11.46 | -4.93 | -10.09 | Upgrade
|
| EBIT Margin | 8.01% | 7.74% | 11.63% | 4.11% | -2.35% | -5.34% | Upgrade
|
| Effective Tax Rate | 27.73% | 69.50% | 30.76% | 73.79% | - | - | Upgrade
|
| Revenue as Reported | 512 | 512 | 382.14 | 278.44 | 209.88 | 188.76 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.